The role of sphingosine kinase and sphingosine-1-phosphate in the regulation of endothelial cell biology

Endothelium: Journal of Endothelial Cell Research

Volumn 15, Issue 3, 2008, Pages 101-112

  Limaye, Vidya ^a,b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Angiogenesis; Endothelial Cells; Inflammation; Sphingosine Kinase; Sphingosine 1 Phosphate

Indexed keywords

5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBROBLAST GROWTH FACTOR; HIGH DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; SPHINGOMYELIN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE KINASE; SPHINGOSINE KINASE 1; SPHINGOSINE KINASE 2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOGENESIS; APOPTOSIS; ATHEROGENESIS; BLOOD VESSEL TONE; CALCIUM MOBILIZATION; CARCINOGENESIS; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HYPERTENSION; INFLAMMATION; INFLAMMATORY DISEASE; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; SHORT SURVEY; SIGNAL TRANSDUCTION; THROMBOCYTE; TISSUE DISTRIBUTION; TUMOR GROWTH; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

BIOLOGY; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; LYSOPHOSPHOLIPIDS; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SPHINGOSINE;

EID: 45949102390     PISSN: 10623329     EISSN: 10292373     Source Type: Journal    
DOI: 10.1080/10623320802125342     Document Type: Short Survey

References (140)

1. Aggarwal, B. B., Shishodia, S., Ashikawa, K. and Bharti, A. C. (2002) The role of TNF and its family members in inflammation and cncer: lessons from gene deletion. Current Drug Targets in Inflammation and Allergy, 1, pp. 327-341.
2. Akao, Y., Banno, Y., Nakagawa, Y., Hasegawa, N., Kim, T. J., Murate, T., Igarashi, Y. and Nozawa, Y. (2006) High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced upregulation. Biochemical and Biophysical Research Communications, 342, pp. 1284-1290.
3. Alemany, R., Van Koppen, C. J., Danneberg, K., ter Braak, M., Meyer, Zu. and Herringdorf, D. (2007) Regulation and functinal roles of sphingosine kinases. Naunyn-Schmiedeberg's Archives of Pharmacology, 374, pp. 413-428.
4. Alewijnse, A. E., Peters, S. L. and Michel, M. C. (2004) Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites. British Journal of Pharmacology, 143, pp. 666-684.
5. An, S., Zheng, Y. and Bleu, T. (2000) Sphingosine 1-phosphate-induced cell proliferation, survival, and related signaling events mediated by G protein-coupled receptors Edg3 and Edg5. Journal of Biological Chemistry, 275, pp. 288-296.
6. Ancellin, N., Colmont, C., Su, J., Li, Q., Mittereder, N., Chae, S. S., Stefansson, S., Liau, G. and Hla, T. (2002) Extracellular export of sphingosine kinase-1 enzyme: Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation. Journal of Biological Chemistry, 277, pp. 6667-6675.
7. Aoki, S., Yatomi, Y., Shimosawa, T., Yamashita, H., Kitayama, J., Tsuno, N. H., Takahashi, K. and Ozaki, Y. (2007) The suppressive effect of sphingosine 1-phosphate on monocyte-endothelium adhesion may be mediated by the rearrangement of the endothelial integrins alpha(5)beta(1) and alpha(V)beta(3). Journal of Thrombosis and Haemostasis, 5, pp. 1292-1301.
8. Banno, Y., Kato, M., Hara, A. and Nozawa, Y. (1998) Evidence for the presence of multiple forms of Sph kinase in human platelets. Biochemistry Journal, 335, pp. 301-304.
9. Benton, A. M., Gerrard, J. M., Michiel, T. and Kindom, S. E. (1982) Are lysophosphatidic acids or phosphatidic acids involved in stimulus activation coupling in platelets?. Blood, 60, pp. 642-649.
10. Blakesley, V. A., Beitner-Johnson, D., Van Brocklyn, J. R., Rani, S., Shen-Orr, Z., Stannard, B. S., Spiegel, S. and LeRoith, D. (1997) Sphingosine 1-phosphate stimulates tyrosine phosphorylation of Crk. Journal of Biological Chemistry, 272, pp. 16211-16215.
11. Bolick, D. T., Srinivasan, S., Kim, K. W., Hatley, M. E., Clemens, J. J., Whetzel, A., Ferger, N., Macdonald, T. L., Davis, M. D., Tsao, P. S., Lynch, K. R. and Hedrick, C. C. (2005) Sphingosine-1-phosphate prevents tumor necrosis factor-a mediated monocyte adhesion to aortic endothelium in mice. Arteriosclerosis Thrombosis Vascular Biology, 25, pp. 976-981.
12. Bolz, S. S., Vogel, L., Sollinger, D., Derwand, R., Boer, C., Pitson, S. M., Spiegel, S. and Pohl, U. (2003) Sphingosine kinase modulates microvascular tone and myogenic responses through activation of RhoA/Rho kinase. Circulation, 108, pp. 342-347.
13. Bornfeldt, K. E., Graves, L. M., Raines, E. W., Igarashi, Y., Wayman, G., Yamamura, S., Yatomi, Y., Sidhu, J. S., Krebs, E. G. and Hakomori, S. (1995) Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: Spatial and temporal modulation of PDGF chemotactic signal transduction. Journal of Cell Biology, 130, pp. 193-206.
14. Brindley, D. N. (2004) Lipid phosphate phosphatases and related proteins: Signaling functions in development, cell division and cancer. Journal of Cell Biochemistry, 92, pp. 900-912.
15. Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., Foster, C. A., Zollinger, M. and Lynch, K. R. (2002) The immune modulator FTY720 targets sphingosine-1-phosphate receptors. Journal of Biological Chemistry, 277, pp. 21453-21457.
16. Bu, S., Yamanka, M., Pei, H., Bielawska, A., Bielawski, J., Hannun, Y. A., Obeid, L. and Trojanowska, M. (2006) Dihydrosphingosine 1-phosphate stimulates MMP1 gene expression via activation of ERK1/2-Ets 1 pathway in human fibroblasts. FASEB Journal, 20, pp. 184-186.
17. Budzyn, K., Marley, P. D. and Sobey, C. G. (2006) Targeting Rho and Rho-kinase in the treatment of cardiovascular disease. Trends in Pharmacological Science, 27, pp. 97-104.
18. Buehrer, B. M., Bardes, E. S. and Bell, R. M. (1996) Protein kinase C-dependent regulation of human erythroleukemia (HEL) cell sphingosine kinase activity. Biochimica et Biophysica Acta, 1303, pp. 233-242.
19. Chalfant, C. E. and Spiegel, S. (2005) Sphingosine-1-phosphate and ceramide-1-phosphate: Expanding roles in cell signalling. Journal of Cell Science, 118, pp. 4605-4612.
20. Chikani, G., Zhu, W. and Smart, E. J. (2004) Lipids: Potential regulators of nitric oxide generation. American Journal of Physiology, Endocrinology and Metabolism, 287, pp. E386-E389.
21. Chun, J., Goetzl, E. J., Hla, T., Igarashi, Y., Lynch, K. R., Moolenaar, W., Pyne, S. and Tigyi, G. (2002) International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature. Pharmacological Reviews, 54, pp. 265-269.
22. Collins, T., Read, M. A., Neish, A. S., Whitley, M. Z., Thanos, D. and Maniatis, T. (1995) Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. Federation Proceedings, 9, pp. 899-909.
23. Coussin, F., Scott, R. H., Wise, A. and Nixon, G. F. (2002) Comparison of sphingosine-1-phosphate-induced intracellular signalling pathways in vascular smooth muscles: Differential role in vasoconstriction. Circulation Research, 91, pp. 151-157.
24. Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, S. and Spiegel, S. (1996) Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature, 381, pp. 800-803.
25. Cuvillier, O., Rosenthal, D. S., Smulson, M. E. and Spiegel, S. (1998) Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas-and ceramide-mediated apoptosis in Jurkat T lymphocytes. Journal of Biological Chemistry, 273, pp. 2910-2916.
26. Damirin, A., Tomura, H., Komachi, M., Tobo, M., Sato, K., Mogi, C., Nochi, H., Tamoto, K. and Okajima, F. (2005) Sphingosine 1-phosphate receptors mediate the lipid-induced cAMP accumulation through cyclooxygenase-1/prostaglandin I2 pathway in human coronary artery smooth muscle cells. Molecular Pharmacology, 67, pp. 1177-1185.
27. Dantas, A. P., Igarashi, J. and Michel, T. (2003) Sphingosine-1-phosphate and control of vascular tone. American Journal of Physiology, 284, pp. H2045-H2052.
28. Delon, C., Manifava, M., Wood, E., Thompson, D., Krugmann, S., Pyne, S. and Ktistakis, N. T. (2004) Sphingosine kinase 1 is an intracellular effector of phospatidic acid. Journal of Biological Chemistry, 279, pp. 44763-44774.
29. Desai, N. N., Zhang, H., Olivera, A., Mattie, M. E. and Spiegel, S. (1992) Sphingosine-1-phosphate, a metabolite of sphingosine, increases phosphatidic acid levels by phospholipase D activation. Journal of Biological Chemistry, 267, pp. 23122-23128.
30. Dudzinski, D. M., Igarishi, J., Greif, D. and Michel, T. (2006) The regulation and pharmacology of endothelial nitric oxide synthase. Annual Review of Pharmacology and Toxicology, 46, pp. 235-276.
31. Durieux, M. E. and Lynch, K. R. (1993) Signalling properties of lysophosphatidic acid. Trends in Pharmacological Sciences, 14, pp. 249-254.
32. Edsall, L. C., Cuvillier, O., Twitty, S., Spiegel, S. and Milstien, S. (2001) Sphingosine kinase expression regulates apoptosis and caspase activation in PC12 cells. Journal of Neurochemistry, 76, pp. 1573-1584.
33. Edsall, L. C., Pirianov, G. G. and Spiegel, S. (1997) Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation. Journal of Neuroscience, 17, pp. 6952-6960.
34. Edsall, L. C., Van Brocklyn, J. R., Cuvillier, O., Kleuser, B. and Spiegel, S. (1998) N'N-Dimethlysphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: Modulation of cellular levels of sphingosine 1-phosphate and ceramide. Biochemistry, 37, pp. 12892-12898.
35. Eichholtz, T., Jalink, K., Fahrenfort, I. and Moolenaar, W. H. (1993) The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochemistry Journal, 291, pp. 677-680.
36. Fueller, M., Wang, D. A., Tigyi, G. and Siess, W. (2003) Activation of human monocytic cells by lysophosphatidic acid and sphingosine 1-phospahate. Cell Signaling, 15, pp. 367-375.
37. Ghosh, T. K., Bian, J. and Gill, D. L. (1990) Intracellular calcium release mediated by sphingosine derivatives generated in cells. Science, 248, pp. 1653-1656.
38. Guo, C., Zheng, C., Martin-Padura, I., Bian, Z. C. and Guan, J. L. (1998) Differential stimulation of proline-rich tyrosine kinase 2 and mitogen-activated protein kinase by sphingosine 1-phosphate. European Journal of Biochemistry, 257, pp. 403-408.
39. Hannun, Y. A. (1996) Functions of ceramide in coordinating cellular responses to stress. Science, 274, pp. 1855-1859.
40. Hemmings, D. G. (2006) Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine. Naunyn-Schmiedeber's Archives of Pharmacology, 373, pp. 18-29.
41. Hemmings, D. G., Hudson, N. K., Halliday, D., O'Hara, M., Baker, P. N., Davidge, S. T. and Taggart, M. J. (2006) Sphingosine-1-phosphate acts via Rho-Associated kinase and Nitric Oxide to regulate human placental vascular tone. Biology of Reproduction, 74, pp. 88-94.
42. Hemmings, D. G., Xu, Y. and Davidge, S. T. (2004) Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats. British Journal of Pharmacology, 143, pp. 276-284.
43. Hla, T. and Maciag, T. (1990) An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. Journal of Biological Chemistry, 265, pp. 9308-9313.
44. Huang, D. C. and Strasser, A. (2000) BH3-Only proteins-essential initiators of apoptotic cell death. Cell, 103, pp. 839-842.
45. Igarashi, J., Bernier, S. G. and Michel, T. (2001) Sphingosine-1-phosphate and activation of endothelial nitric oxide synthase: Differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. Journal of Biological Chemistry, 276, pp. 12420-12426.
46. Igarashi, Y. and Hakomori, S. (1989) Enzymatic synthesis of N,N′-dimethylsphingosine:dEmonstration of the sphingoisne: N-methyltransferase in mouse brain. Biochemical and Biophysical Research Communications, 164, pp. 1411-1416.
47. Inagaki, Y., Li, P. Y., Wada, A., Mitsutake, S. and Igarashi, Y. (2003) Identification of functional nuclear export sequences in human sphingosine kinase 1. Biochemical and Biophysical Research Communications, 311, pp. 168-173.
48. Ishii, I., Ye, X., Friedman, B., Kawamura, S., Contos, J. J., Kingsbury, M. A., Yang, A. H., Zhang, G., Brown, J. H. and Chun, J. (2002) Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1-phosphate (S1P) receptors, S1P (2)/LP (B2)/EDG-5 and S1P(3)/LP(B3)/EDG-3. Journal of Biological Chemistry, 277, pp. 25152-25159.
49. Itagaki, K., Yun, J. K., Hengst, J. A., Yatani, A., Hauser, C. J., Spolarics, Z. and Deitch, E. A. (2007) Journal of Pharmacology and Experimental Therapeutics, 323, pp. 186-191.
50. Keenan, R. W. and Haegelin, B. (1969) The enzymatic phosphorylation of sphinganine. Biochemical and Biophysical Research Communications, 37, pp. 888-894.
51. Keenan, R. W. and Maxam, A. (1969) The in vitro degradation of dihydrosphingosine. Biochimica et Biophysica Acta, 176, pp. 348-356.
52. Khan, W. A., Dobrowsky, R., el Touny, S. and Hannun, Y. A. (1990) Protein kinase C and platelet inhibition by D-erythro-sphingosine: comparison with N.,N-dimethylsphingosine and commercial prepearation. Biochemical and Biophysical Research Communications, 172, pp. 683-691.
53. Kimura, T., Sato, K., Kuwubara, A., Tomura, H., Ishiwara, M., Kobayashi, I., Ui, M. and Okajima, F. (2001) Sphingosine-1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells. Journal of Biological Chemistry, 276, pp. 31780-31785.
54. Kimura, T., Sato, K., Malchinkhuu, E., Tomura, H., Tamama, K., Kuwabara, A., Murukami, M. and Okajima, F. (2003) High density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors. Arteriosclerosis and Thrombosis Vascular Biology, 23, pp. 1283-1288.
55. Kluk, M. J. and Hla, T. (2002) Signaling of sphingosine 1-phosphate via the S1P/EDG family of G-protein coupled receptors. Biochimica et Biophysica Acta, 1582, pp. 72-80.
56. Kohama, T., Olivera, A., Edsall, L., Nagiec, M. M., Dickson, R. and Spiegel, S. (1998) Molecular cloning and functional characterization of murine sphingosine kinase. Journal of Biological Chemistry, 273, pp. 23722-23728.
57. 2+ in human monocytes. Journal of Pharmacological Science, 100, pp. 289-296.
58. Lee, M. J., Thangada, S., Claffey, K. P., Ancellin, N., Liu, C. H., Kluk, M., Volpi, M., Sha'afi, R. J. and Hla, T. (1999) Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell, 99, pp. 301-312.
59. Lee, M. J., Van Brocklyn, J. R., Thangada, S., Liu, C. H., Hand, A. R. Menzeleev, R. et al. (1998) Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science, 279, pp. 1552-1555.
60. Lee, O. H., Kim, Y. M., Lee, Y. M., Moon, E. J., Lee, D. J., Kim, J. H., Kim, K. W. and Kwon, Y. J. (1999) Sphingosine 1-phosphate induces angiogenesis: Its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochemical and Biophysical Research Communications, 264, pp. 743-750.
61. Lee, S. Y., Reichlin, A., Santana, A., Sokol, K. A., Nussenzweig, M. C. and Choi, Y. (1997) TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival. Immunity, 7, pp. 703-713.
62. Li, X., Stankovic, M., Bonder, C. S., Hahn, C. N., Parsons, M., Pitson, S. M., Xia, P., Proia, R. L., Vadas, M. A. and Gamble, J. R. (2008) Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1. Blood, 111:7, pp. 3489-3497.
63. Liao, J. J., Huang, Y. T. and Lee, H. (2005) Inhibitory effects of sphingosine-1-phosphate on proliferation of PC3 human prostate cancer cells. Zoological Studies, 44, pp. 219-227.
64. Limaye, V., Li, X., Hahn, C., Xia, P., Berndt, M. C., Vadas, M. A. and Gamble, J. R. (2005) Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family members. Blood, 105, pp. 3169-3177.
65. Liu, H., Sugiura, M., Nava, V. E., Edsall, L. C., Kono, K. Poulton, S. et al. (2000) Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. Journal of Biological Chemistry, 275, pp. 19513-19520.
66. Liu, H., Toman, R. E., Goparuju, S., Maceyka, M., Nava, V. E., Sankala, H., Payne, S. G., Bektas, M., Ishii, I., Chun, J., Milstein, S. and Spiegel, S. (2003) Sphingosine kinase type 2 is a putative BH3-Only protein that induces apoptosis. Journal of Biological Chemistry, 278, pp. 40330-40336.
67. Louie, D. D., Kisic, A. and Schroefer Jr., G. J. (1976) Sphingolipid base metabolism. Partial purification and properties of sphinganine kinase of brain. Journal of Biological Chemistry, 251, pp. 4557-4564.
68. Manggau, M., Kim, D. S., Ruwisch, L., Vogler, R., Korting, H. C., Schafer-Korting, M. and Kleuser, B. (2001) 1α,25-Dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. Journal of Investigative Dermatology, 117, pp. 1241-1249.
69. Martino, A., Volpe, E., Auricchio, G., Izzi, V., Poccia, F., Mariani, F., Coliaai, V. and Baldini, P. M. (2007) Sphingosine 1-phosphate interferes on the differentiation of human monocytes into competent dendritic cells. Scandinavian Journal of Immunology, 65, pp. 84-91.
70. Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L. and Cyster, J. G. (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature, 427, pp. 355-360.
71. Mazurek, N., Megidish, T., Hakomori, S. and Igarashi, Y. (1994) Regulatory effect of phorbol esters on sphingosine kinase in BALB/C 3T3 fibroblasts (variant A31): Demonstration of cell type-specific response-a preliminary note. Biochemical and Biophysical Research Communications, 198, pp. 1-9.
72. 2+ mediates rac activation and adherens junction assembly in endothelial cells. Journal of Biological Chemistry, 280, pp. 17320-17328.
73. Melendez, A., Floto, R. A., Gillooly, D. J., Harnett, M. M. and Allen, J. M. (1998) FcgammaRI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking. Journal of Biological Chemistry, 273, pp. 9393-9402.
74. Meyer, Z. u., Herringdorf, D., Himmel, H. M. and Jakobs, K. H. (2002) Sphingosylphosphorylcholine-biological functions and mechanisms of action. Biochimica et Biophysica Acta, 1582, pp. 178-189.
75. Michel, M. C., Mulders, A CM, Jongsma, M., Alewijnse, A. E. and Peters, S. L. M. (2007) Vascular effects of sphingolipids. Acta Paediatrica, 96, pp. 44-48.
76. Mulders, A. C. M., Hendriks-Balk, M. C., Mathy, M. J., Michel, M. C., Alewijnse, A. E. and Peters, S. L. M. (2006) Sphingosine kinase-dependent activation of endothelial nitric oxide synthase by angiotensin II. Arteriosclerosis Thrombosis Vascular Biology, 26, pp. 2043-2048.
77. Mulders, A. C. M., Nau, S., Li, Y. and Michel, M. C. (2007) Effects of sphingosine-1-phosphate and sphingosylphosphorylcholine on intracellular Ca2+ and cell death in prostate cancer cell lines. Autonomic and Autacoid Pharmacology, 27, pp. 173-179.
78. Murata, N., Sato, K., Kon, J., Tomura, H., Yanagita, M., Kuwabara, A., Ui, M. and Okajima, F. (2000) Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochemistry Journal, 352, pp. 809-815.
79. Murate, T., Banno, Y., Koizumi, K., Watanabe, K., Mori, N., Wada, A., Igarashi, Y., Takagi, A., Kojina, T., Asano, H., Akao, Y., Yoshida, S., Saito, H. and Nozawa, Y. (2001) Cell type-specific localization of sphingosine kinase 1a in human tissues. Journal of Histochemistry and Cytochemistry, 49, pp. 845-855.
80. Naetzker, S., Hagen, N. and Echten-Deckert, G. (2006) Activation of p38 mitogen-activated protein kinase and partial reactivation fot eh cell cycle by cis-4-methyl sphingosine direct on postmitotic neurons towards apoptosis. Genes Cells, 11, pp. 269-279.
81. Nagiec, M. M., Skrzypek, M., Nagiec, E. E., Lester, R. L. and Dickson, R. C. (1998) The LCB4 (YOR171c) and LCB5 (YLR260w) genes of Saccharomyces encode sphingoid long chain base kinases. Journal of Biological Chemistry, 273, pp. 19437-19442.
82. Naismith, J. H. and Sprang, S. R. (1998) Modularity in the TNF-receptor family. Trends in Biochemical Sciences, 23, pp. 74-79.
83. Nava, V. E., Hobson, J. P., Murthy, S., Milstein, S. and Spiegel, S. (2002) Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. Experimental Cell Research, 281, pp. 115-127.
84. Nishitoh, H., Saitoh, M., Mochida, Y., Takeda, K., Nakano, H., Rothe, M., Miyazono, K. and Ichijo, H. (1998) ASPHK1 is essential for JNK/SAPK activation by TRAF2. Molecular Cell, 2, pp. 389-395.
85. Nofer, J. R. and Assmann, G. (2005) Atheroprotective effects of high-density lipoprotein-associated lysosphingolipids. Trends in Cardiovascular Medicine, 15, pp. 265-271.
86. Nofer, J. R., van der Giet, M., Tolle, M., Wolinska, I., von Wnuck Lipinski, K., Baba, H. A., Tietge, U. J., Godecke, A., Ishii, I., Kleuser, B., Schafers, M., Fobker, M., Zidek, W., Assmann, G., Chun, J. and Levkau, B. (2004) HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. Journal of Clinical Investigation, 113, pp. 569-581.
87. Okajima, F. (2002) Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: Is this an atherogenic mediator or an anti-atherogenic mediator?. Biochimica et Biophysica Acta, 1582, pp. 132-137.
88. 2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition. Journal of Biological Chemistry, 273, pp. 27104-27110.
89. Olivera, A., Kohama, T., Tu, Z., Milstien, S. and Spiegel, S. (1998) Purification and characterization of rat kidney sphingosine kinase. Journal of Biological Chemistry, 273, pp. 12576-12583.
90. Olivera, A. and Spiegel, S. (1993) Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature, 365, pp. 557-560.
91. Pchejetski, D., Golzio, M. and Bonhoure, E. (2005) Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer Research, 65, pp. 1167-1175.
92. Pitson, S. M., D'andrea, R. J., Vandeleur, L., Moretti, P. A., Xia, P., Gamble, J. R., Vadas, M. A. and Wattenberg, B. W. (2000) Human sphingosine kinase: Purification, molecular cloning and characterization of the native and recombinant enzymes. Biochemistry Journal, 350, pp. 429-441.
93. Pitson, S. M., Moretti, P. A. B., Zebol, J. R., Lynn, H. E., Xia, P., Vadas, M. A. and Wattenberg, B. W. (2003) Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO Journal, 22, pp. 5491-5500.
94. Pitson, S. M., Moretti, P. A., Zebol, J. R., Xia, P., Gamble, J. R., Vadas, M. A., D'Andrea, R. J. and Wattenberg, B. W. (2000) Expression of a catalytically inactive sphingosine kinase mutant blocks agonist-induced sphingosine kinase activation. A dominant-negative sphingosine kinase. Journal of Biological Chemistry, 275, pp. 33945-33950.
95. Pitson, S. M., Moretti, P. A., Zebol, J. R., Zareie, R., Derian, C. K., Darrow, A. L., Qi, J., D'Andrea, R. J., Bagley, C. J., Vadas, M. A. and Wattenberg, B. W. (2003) The nucleotide-binding site of human sphingosine kinase 1. Journal of Biological Chemistry, 277, pp. 49545-49553.
96. Pitson, S. M., Xia, P., Leclercq, T. M., Moretti, P. A., Zebol, J. R., Lynn, H. E., Wattenberg, B. W. and Vadas, M. A. (2005) Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signaling. Journal of Experimental Medicine, 201, pp. 49-54.
97. Pyne, S., Long, J. S., Ktistakis, N. T. and Pyne, N. J. (2005) Lipid phosphate phosphatases and lipid phosphate signaling. Biochemical Society Transactions, 33, pp. 1370-1374.
98. Pyne, S. and Pyne, N. J. (2000) Sphingosine 1-phosphate signalling in mammalian cells. Biochemistry Journal, 349, pp. 385-402.
99. Rius, R. A., Edsall, L. C. and Spiegel, S. (1997) Activation of sphingosine kinase in pheochromocytoma PC12 neuronal cells in response to trophic factors. FEBS Letters, 417, pp. 173-176.
100. Rothe, M., Sarma, V., Dixit, V. M. and Goeddel, D. V. (1995) TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science, 269, pp. 1424-1427.
101. Sanna, M. G., Wang, S. K., Gonzalez-Cabrera, P. J., Don, A., Marsolais, D., Matheu, M. P., Wei, S. H., Parker, I., Jo, E., Cheng, W. C., Cahalan, M. D., Wong, C. H. and Rosen, H. (2006) Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nature Chemical Biology, 2, pp. 434-441.
102. Sato, K., Tomura, H., Igarashi, Y., Ui, M. and Okajima, F. (1999) Possible involvement of cell surface receptors in sphingosine 1-phosphate-induced activation of extracellular signal-regulated kinase in C6 glioma cells. Molecular Pharmacology, 55, pp. 126-133.
103. Schwalm, S., Doll, F., Romer, I., Bubnova, S., Pfeilschifter, J. and Huwiler, A. (2008) Sphingosine kianse-1 is a hypoxia-regulated gene that stimulates migration of human endothelial cells. Biochemistry and Biophysical Research Communications, 368:4, pp. 1020-1025.
104. Shaul, P. W. and Mineo, C. (2004) HDL action on the vascular wall: Is the answer NO?. Journal of Clinical Investigation, 113, pp. 509-513.
105. 2+ sensitization in the bovine cerebral artery: Unimportant role for protein kinase C. Circulation Research, 91, pp. 112-119.
106. Spiegel, S. and Milstein, S. (2003) Sphingosine-1-phosphate:aN enignmatic signalling lipid. Nature Reviews in Molecular Cell Biology, 4, pp. 397-407.
107. Stoffel, W., Assmann, G. and Binczek, E. (1970) Metabolism of sphingosine bases. 13. Enzymatic synthesis of 1-phosphate esters of 4t-sphingenine (sphingosine), sphinganine (dihydrosphingosine), 4-hydroxysphinganine (phytosphingosine) and 3-dehydrosphinganine by erythrocytes. Hoppe-Seyler's Zeitschrift fur physiologische Chemie, 351, pp. 635-642.
108. Stoffel, W., Heimann, G. and Hellenbroich, B. (1973) Sphingosine kinase in blood platelets. Hoppe-Seyler's Zeitschrift fur physiologische Chemie, 354, pp. 562-566.
109. Stoffel, W., Hellenbroich, B. and Heimann, G. (1973) Properties and specificities of sphingosine kinase from blood platelets. Hoppe-Seyler's Zeitschrift fur physiologische Chemie, 354, pp. 1311-1316.
110. Su, Y., Rosenthal, D., Smulson, M. and Spiegel, S. (1994) Sphingosine 1-phosphate, a novel signaling molecule, stimulates DNA binding activity of AP-1 in quiescent Swiss 3T3 fibroblasts. Journal of Biological Chemistry, 269, pp. 16512-16517.
111. Sukocheva, O. A., Wang, L., Albanese, N., Pitson, S. M., Vadas, M. A. and Xia, P. (2003) Sphingosine kinase transmits estrogen signalling in human breast cancer cells. Molecular Endocrinology, 17, pp. 2002-2012.
112. Taha, T. A., Kitatani, K., el Alwani, M., Bielawski, J., Hannun, Y. A. and Obeid, L. M. (2006) Loss of sphingosine kinase-1 activates the intrinsic pathway of programmed cell death: Modulation of sphingolipid levels and the induction of apoptosis. FASEB Journal, 20, pp. 482-484.
113. Tani, M., Kawakami, A., Nagai, M., Shimokado, K., Kondo, K. and Yoshida, M. (2007) Sphingosine 1-phosphate (S1P) inhibits monocyte-endothelial cell interaction by regulating of RhoA activity. FEBS Letters, 581, pp. 4621-4626.
114. Thompson, C. R., Iyer, S. S., Melrose, N., VanOosten, R., Johnson, K., Pitson, S. M., Obeid, L. M. and Kusner, D. J. (2005) Sphingosine kinase 1 (SK1) is recruited to nascent phagosomes in human macrophages: Inhibition of SK1 translocation by Mycobacterium tuberculosis. Journal of Immunology, 174, pp. 3551-3561.
115. Tolle, M., Levkau, B., Kleuser, B. and van der Giet, M. (2007) Sphingosine-1-phosphate and FTY720 as anti-atherosclerotic lipid compounds. European Journal of Clinical Investigations, 37, pp. 171-179.
116. Van Brocklyn, J. R., Lee, M. J., Menzeleev, R., Olivera, A., Edsall, L., Cuvillier, O., Thomas, D. M., Coopman, P. J., Thangada, S., Liu, C. H., Hla, T. and Spiegel, S. (1998) Dual actions of sphingosine-1-phosphate: Extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. Journal of Cell Biology, 142, pp. 229-240.
117. Van Veldhoven, P. P. and Mannaerts, G. P. (1991) Subcellular localization and membrane topology of sphingosine-1-phosphate lyase in rat liver. Journal of Biological Chemistry, 266, pp. 12502-12507.
118. Van Veldhoven, P. P. and Mannaerts, G. P. (1993) Sphingosine-phosphate lyase. Advances in Lipid Research, 26, pp. 69-98.
119. Venkataraman, K., Thangada, S., Michaud, J., Oo, M. L., Ai, Y., Lee, Y. M., Wu, M., Parikh, N. S., Khan, F., Proia, R. L. and Hla, T. (2006) Extracellular export of sphingosine kinase 1a contributes to the vascular S1P gradient. Biochemistry Journal, 397, pp. 461-471.
120. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V. and Baldwin Jr., A. S. (1998) NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science, 281, pp. 1680-1683.
121. Wang, F., Nobes, C. D., Hall, A. and Spiegel, S. (1997) Sphingosine 1-phosphate stimulates rho-mediated tyrosine phosphorylation of focal adhesion kinase and paxillin in Swiss 3T3 fibroblasts. Biochemistry Journal, 324, pp. 481-488.
122. Wang, F., Van Brocklyn, J. R., Hobson, J. P., Movafagh, S., ZukowSphKa-Grojec, Z., Milstien, S. and Spiegel, S. (1999) Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor. Potential involvement in angiogenesis. Journal of Biological Chemistry, 274, pp. 35343-35350.
123. Wattenberg, B. W., Pitson, S. M. and Raben, D. M. (2006) The sphingosine diacylglycerol kinase superfamily of signalling kinases: Localization as a key to signalling function. Journal of Lipid Research, 47, pp. 1128-1139.
124. Xia, P., Gamble, J. R., Rye, K. A., Wang, L., Hii, C. S., Cockerill, P., Khew-Goodall, Y., Bert, A. G., Barter, P. J. and Vadas, M. A. (1998) Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. Procedings of the National Academy of Sciences of the United States of America, 95, pp. 14196-14201.
125. Xia, P., Gamble, J. R., Wang, L., Pitson, S. M., Moretti, P. A., Wattenberg, B. W., D'Andrea, R. J. and Wattenberg, B. W. (2000) An oncogenic role of sphingosine kinase. Current Biology, 10, pp. 1527-1530.
126. Xia, P., Vadas, M. A., Rye, K. A., Barter, P. J. and Gamble, J. R. (1999) High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against atherosclerosis by HDL. Journal of Biological Chemistry, 274, pp. 33143-33147.
127. Xia, P., Wang, L., Gamble, J. R. and Vadas, M. A. (1999) Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells. Journal of Biological Chemistry, 274, pp. 34499-34505.
128. Xia, P., Wang, L., Moretti, P. A., Albanese, N., Chai, F., Pitson, S. M., D'Andrea, R. J., Gamble, J. R. and Vadas, M. A. (2002) Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor signalling. Journal of Biological Chemistry, 277, pp. 7996-8003.
129. Xie, J. H., Nomura, N., Koprak, S. L., Quackenbush, E. J., Forrest, M. J. and Rosen, H. (2003) Sphingosine-1-phosphate receptor agonism impairs the efficacy of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells. Journal of Immunology, 170, pp. 3662-3670.
130. Xu, M., Waters, C. L., Hu, C., Wysolmerski, R. B., Vincent, P. A. and Minnear, F. L. (2007) Sphingosine-1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase. American Journal Physiology and Cell Physiology, 293, pp. C1309-C13018.
131. Yan, G., Chen, S., You, B. and Sun, J. (2008) Activation of sphingosine kinase-1 mediates induction of endothelial cell proliferatin and angiogneesis by epoxyeicosatrienoic acids. Cardiovascular Research, 78:2, pp. 308-314.
132. Yang, L., Yatomi, Y., Hisano, N., Qi, R., Asazuma, N., Satoh, K., Igarashi, Y., Ozaki, Y. and Kume, S. (1996) Activation of protein-tyrosine kinase Syk in human platelets stimulated with lysophosphatidic acid or sphingosine 1-phosphate. Biochemical and Biophysical Research Communications, 229, pp. 440-444.
133. Yatomi, Y., Igarashi, Y., Yang, L., Hisano, N., Qi, R., Asazuma, N., Satoh, K., Ozaki, Y. and Kume, S. (1997) Sphingosine-1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. Journal of Biochemistry (Tokyo), 121, pp. 969-973.
134. Yatomi, Y., Ruan, F., Hakomori, S. and Igarashi, Y. (1995) Sphingosine-1-phosphate: A platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood, 86, pp. 193-202.
135. Yatomi, Y., Yamamura, S., Ruan, F. and Igarashi, Y. (1997) Sphingosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid. Journal of Biological Chemistry, 272, pp. 5291-5297.
136. Ye, H., Park, Y. C., Kreishman, M., Kieff, E. and Wu, H. (1999) The structural basis for the recognition of diverse receptor sequences by TRAF2. Molecular Cell, 4, pp. 321-330.
137. Ye, H. and Wu, H. (2000) Thermodynamic characterization of the interaction between TRAF2 and tumor necrosis factor receptor peptides by isothermal titration calorimetry. Procedings of the National Academy of Sciences of the United States of America, 97, pp. 8961-8966.
138. Yeh, W. C., Shahinian, A., Speiser, D., Kraunus, J., Billia, F., Wakeham, A., de la Pompa, J. L., Ferrick, D., Hum, B., Iscove, N., Ohashi, P., Rothe, M., Goeddel, D. V. and Mak, T. W. (1997) Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity, 7, pp. 715-725.
139. Zhang, H., Desai, N. N., Olivera, A., Seki, T., Brooker, G. and Spiegel, S. (1991) Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. Journal of Cell Biology, 114, pp. 155-167.
140. Zondag, G. C., Postma, F. R., Etten, I. V., Verlaan, I. and Moolenaar, W. H. (1998) Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1. Biochemistry Journal, 330, pp. 605-609.